Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-058 manufacturers

Filters

1 products found

pp-058

Tablets

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA, EU GMP
Registered in
Australia , Austria , Bulgaria , China , Czech Republic , Denmark , Finland , France , Germany , Hong Kong , Italy , Malta , Netherlands , New Zealand , Norway , Poland , Romania , Spain , Sweden , Taiwan , United Kingdom , United States
Comments
Indication: Relapsed or refractory diffuse large B-cell lymphoma in patients who have progressed after multiple prior systemic therapies. Clinical stage: Commercialized in several regions with ongoing clinical development in additional hematologic malignancy settings. Modality: Small molecule Mechanism / Target: Selective inhibitor of nuclear export acting on XPO1 to block nuclear export of tumor suppressor proteins and disrupt oncogenic signaling. Route / form: Oral tablets Differentiation: First-in-class selective nuclear export inhibitor with demonstrated activity in heavily pretreated lymphoma populations and a distinct mechanism from existing cytotoxic or targeted agents.
Manufacturer #38613

A clinical-stage biopharmaceutical company advancing innovative cancer medicines from early discovery through commercialization. It focuses on targeted oncology and immuno-oncology therapeutics to address unmet needs through global development and strategic partnerships. The organization integrates R&D, manufacturing, and commercialization efforts (US, CN)

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.